BridgeBio Pharma LLC

Insider CIK 1743881 · EIDX 10% owner · BBOT 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
BBOT BridgeBio Oncology Therape	J Other	2025-10-10	2025-10-16	784,720	—	$0	14,589,846	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2021-01-26	2021-01-26	14,428,836	—	$0	1,000	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2019-07-03	2019-07-08	882,353	$29.90	$26.38M	24,575,501	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2019-05-24	2019-05-29	1,103,848	$25.93	$28.62M	23,693,148	SEC↗
EIDX Eidos Therapeutics, Inc.	S Sale	2018-12-10	2018-12-12	2,664	$13.96	$37.2K	22,589,300	SEC↗
EIDX Eidos Therapeutics, Inc.	S Sale	2018-12-10	2018-12-12	37,989	$13.29	$504.9K	22,586,636	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-12-10	2018-12-13	37,989	$13.29	$504.9K	22,586,636	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-12-10	2018-12-13	2,664	$13.96	$37.2K	22,589,300	SEC↗
EIDX Eidos Therapeutics, Inc.	S Sale	2018-12-07	2018-12-10	36,314	$13.94	$506.2K	22,543,787	SEC↗
EIDX Eidos Therapeutics, Inc.	S Sale	2018-12-07	2018-12-10	4,860	$14.36	$69.8K	22,548,647	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-12-07	2018-12-13	36,314	$13.94	$506.2K	22,543,787	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-12-07	2018-12-13	4,860	$14.36	$69.8K	22,548,647	SEC↗
EIDX Eidos Therapeutics, Inc.	S Sale	2018-12-06	2018-12-10	38,970	$13.34	$519.9K	22,507,473	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-12-06	2018-12-13	38,970	$13.34	$519.9K	22,507,473	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-12-05	2018-12-06	1,103,848	$14.01	$15.46M	22,468,503	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-12-03	2018-12-06	1,750,000	$15.50	$27.13M	21,364,655	SEC↗
EIDX Eidos Therapeutics, Inc.	X Exercise deriv	2018-06-22	2018-06-26	332,262	—	$0	0	SEC↗
EIDX Eidos Therapeutics, Inc.	X Exercise deriv	2018-06-22	2018-06-26	332,262	—	$0	2,909,029	SEC↗
EIDX Eidos Therapeutics, Inc.	C Conversion deriv	2018-06-22	2018-06-26	2,909,029	—	$0	0	SEC↗
EIDX Eidos Therapeutics, Inc.	C Conversion deriv	2018-06-22	2018-06-26	12,832,123	—	$0	0	SEC↗
EIDX Eidos Therapeutics, Inc.	P Buy	2018-06-22	2018-06-26	1,000,000	$17.00	$17.00M	19,614,655	SEC↗
EIDX Eidos Therapeutics, Inc.	F Tax w/h	2018-06-22	2018-06-26	211,762	$17.00	$3.60M	18,614,655	SEC↗
EIDX Eidos Therapeutics, Inc.	C Conversion	2018-06-22	2018-06-26	18,826,417	—	$0	18,826,417	SEC↗